Loring Wolcott & Coolidge Fiduciary Advisors LLP Insulet Corp Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.1 Billion
- Q3 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Insulet Corp stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,030 shares of PODD stock, worth $274,567. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,030
Previous 1,030
-0.0%
Holding current value
$274,567
Previous $207,000
15.46%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PODD
# of Institutions
687Shares Held
62.6MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.26 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.07 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.62 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$777 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$607 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.5B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...